The PennZone

  • Home
  • Non-profit
  • Music
  • Books
  • Entertainment
  • Marketing
  • Legal
  • Health
  • Technology

Tampa President & Firm Found Guilty of Fraud - Plaintiff Awarded Nearly $1 Million
The PennZone/10062485

Trending...
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
  • Turnstone Creative Welcomes Giovanni Amodei as Manager of Strategic Growth
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
Freddy Russian and his company American Private Equity based in Tampa, Florida found guilty of Fraud and Breach of Contract in U.S. Federal Court. Plaintiff The Prosyon Group was awarded nearly $1 million after a 4 day trial on June 26, 2019.

TAMPA, Fla. & MIAMI & OKLAHOMA CITY - PennZone -- An eight person jury unanimously decided against Freddy Russian and his firm for Fraud & Breach of Contract after a four day trial based on insurmountable evidence and witness testimony. The verdict is related to M&A services rendered by The Prosyon Group after it was contracted when Freddy Russian and his firm couldn't deliver for Brazil-based Quimatec Produtos Quimicos.

More on The PennZone
  • BetQL Brings Data Driven 5 Star Betting Insights to the Everyday Sports Bettor
  • Sky Quarry's Big Turning Point: CEO Marcus Laun Outlines the Next Phase for N A S D A Q: SKYQ
  • Hunter Is Releasing New Music For The Holidays!
  • Tixpool.com - Naija Premier Event Reseller
  • Work 365 Expands Distributor Integrations with Companial for Microsoft Partners

The Prosyon Group not only procured a buyer in Solenis Inc but also provided advisory services to Quimatec management and the two shareholder families in what resulted in a successful transaction. However, once the work was completed Freddy Russian and his firm chose to not honor the original contract and engage in fraudulent activities to do so as was determined in U.S. Federal Court. The Prosyon Group provides M&A consulting services to families and international financial and strategic buyers.

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION Case No:  8:18-cv-587-T-23JSS

Contact
The Prosyon Group
***@gmail.com


Source: The Prosyon Group

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • HW Foundation Opens Nominations for Inaugural 50 Under 50 in AI; Deadline Oct. 16
  • Pavillon 30 Years of Addiction Recovery in Western North Carolina, Earns National Accreditation
  • ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains
  • BJJ App mmaGPT Expands Academy Program to Support Jiu-Jitsu Instructors with AI Technique Coaching
  • Ten Ten Ten Announces Maximizing Clinical Operations
  • Turnstone Creative Welcomes Giovanni Amodei as Manager of Strategic Growth
  • CardsNearby Launches Free Nationwide Directory of Card Shows and Local Card Shops for Collectors
  • American Garden Rose Selections™ Announces 2027 Winners
  • Crossroads4Hope Launches Blood Cancer Resource Hub
  • Wilson Venture Capital to Launch News Organization; Will Name Trevor Wilson CEO
  • NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
  • Georgia's Magical Nights of Lights Bigger and Brighter for 2026
  • Bicentennial Occult Outing Alternative History Video Series Launches for Spooky Season
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
  • "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME
  • Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month
  • Indianapolis Criminal Defense Firm Rigney Law LLC Relaunches Criminal Law Podcast "Tales from the Brown Desk"

Popular on PennZone

  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Lake Norman Philharmonic - Free Community Concert
  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Garage door installation or repair in Minnesota? Which makes more sense for your family?
  • A New Tale Band Makes 9/11 Tribute Song "The Twins" Free for Ceremonies and School Programs
  • New Bethany's 35th Annual Souper Day to Spotlight Connection Between Health, Hunger and Housing
  • Regcrest LLC Publishes Free 50-State Tax Account Closure Checklist Tool
  • Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
  • The Culture and Travel Report Enters a New Chapter as Travel and Hospitality Brands Take Notice

Similar on PennZone

  • Sky Quarry's Big Turning Point: CEO Marcus Laun Outlines the Next Phase for N A S D A Q: SKYQ
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Growth Story Expands: $54.6M Contract, $30M Revenue Run Rate, 800+ Customers, 50+ Patents & New AI Cybersecurity Products for Cycurion, Inc $CYCU
  • Sky Quarry Restarts Nevada's Only Crude Oil Refinery — A Major New Chapter Begins in This Highly Lucrative sector for N A S D A Q: SKYQ
  • Transformational $104 Million Musculoskeletal Healthcare Opportunity as Expansion Strategy Accelerates for Cardiff Lexington Corp (Stock Symbol: CDIX)
  • Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us